CB1 Polyclonal Antibody

CNR1 encodes one of two cannabinoid receptors. The cannabinoids, principally delta-9-tetrahydrocannabinol and synthetic analogs, are psychoactive ingredients of marijuana. The cannabinoid receptors are members of the guanine-nucleotide-binding protein (G-protein) coupled receptor family, which inhibit adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. The two receptors have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. Multiple transcript variants encoding two different protein isoforms have been described for this gene.

The CB1 Polyclonal Antibody is a highly specific and sensitive antibody designed for the detection of the cannabinoid receptor 1 (CB1) protein. This antibody is produced using a polyclonal approach, which ensures a high degree of specificity and sensitivity for the target protein. The CB1 Polyclonal Antibody is suitable for use in a variety of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

This antibody has been rigorously tested for its specificity and sensitivity, ensuring reliable and reproducible results. It has been validated for use in a range of species, including human, mouse, and rat. The CB1 Polyclonal Antibody is supplied in a convenient format, with a concentration of 1 mg/ml, allowing for easy and efficient use in a variety of experimental settings.

In summary, the CB1 Polyclonal Antibody is a highly specific and sensitive antibody that is ideal for the detection of the CB1 protein in a range of applications. Its rigorous validation and convenient format make it an excellent choice for researchers seeking reliable and reproducible results.